Slides
Page 1
Pioneering access for patients Richard Saynor, CEO J.P. Morgan Healthcare Conference January 2026
Page 2
Disclaimer This presentation contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside of the control of Sandoz. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sandoz undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law. This presentation includes non-IFRS financial measures as defined by Sandoz. An explanation of non-IFRS measures can be found in the Supplementary financial information of the Half-Year Report 2025. Certain figures contained in this presentation, including financial information presented in billions or millions, certain operating data and percentages describing financial information or market shares, have been subject to rounding. Dollar values and percentages may not agree to totals. JP Morgan Healthcare Conference
Page 3
Agenda Document title3 Establishing our edge Executing with impact Shaping the future Questions Q&A Richard Saynor, CEO | Remco Steenbergen, CFO
Page 4
Establishing our edge
Page 5
5 Sandoz uniqueness: scale, trust and impact Three pillars defining leadership in biosimilars and generics • Focused model; trusted execution • Only pure-play biosimilars and generics company with global reach • Trusted partner across healthcare systems • Empowered teams driving impact • Outstanding leadership team • 23,000+ committed colleagues • Global scale, robust supply network • Around 1,300 products to 100+ countries • Strong internal and external manufacturing capabilities Sandoz Purpose-led People-driven Global reach Establishing our edge